Clinical Trial Update: Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma [Phase 2]

View source ↗

Summary

The Meir Medical Center-sponsored Phase 2 trial evaluating the efficacy and safety of a statin for progressive smoldering multiple myeloma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoldering Multiple Myeloma

Drugs mentioned

• Statin (statin)

Snippet

Sponsor: Meir Medical Center | Conditions: Smoldering Multiple Myeloma | Phase 2 | Status: WITHDRAWN